The Influence of Short-term Starvation on Hepatitis B Virus Load
NCT02364661 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2015-02-18
Summary
Hepatitis B virus is a small DNA virus that affects 400 million people worldwide. The virus infects the liver and previous studies, done in tissue culture and in animals, have shown that viral replication is affected by metabolic changes occurring in the liver. Specifically, starvation induces HBV gene expression and replication, in parallel to the activation of the gluconeogenesis response, and feeding attenuates viral activity. In this study we are going to recruit HBV patients with detectable viremia and analyze their viral load after an over night starvation versus after a morning meal. Our hypothesis is that following an over-night starvation viral load will be higher than that in the fed state.
Conditions
- Starvation
- Infection
Interventions
- BEHAVIORAL
-
Over night starvation (fasting)
HBV viral load will be analyzed after over-night starvation versus following a morning meal
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Amir Shlomai, MD/PhD · Rabin Medical Center, Beilinson hospital
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-03-31
- Primary Completion
- 2016-03-31
More Related Trials
-
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection
NCT07024641 ·Status: RECRUITING ·Phase: PHASE1
-
Treatment of Hepatitis B in Resource-limited Settings - a Pilot Program in East Africa
NCT02344498 ·Status: ACTIVE_NOT_RECRUITING
-
Study of the Cellular Response Induced After Vaccination Against the Hepatitis B Virus
NCT06876467 ·Status: RECRUITING
-
A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B
NCT04426968 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B
NCT04896255 ·Status: RECRUITING
-
Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients
NCT00715715 ·Status: WITHDRAWN ·Phase: NA
-
Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders
NCT00704106 ·Status: COMPLETED
-
The Effect of Anti-viral Drugs Used in Late Pregnancy on Long-term Development of Children
NCT02301650 ·Status: UNKNOWN
-
Optimal Time for Tenofovir Treatment of Anti-Hepatitis B Virus (HBV) During the Pregnancy
NCT02510963 ·Status: UNKNOWN ·Phase: NA
-
Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B
NCT00230503 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Efficacy and Safety of Tenofovir Disoproxil Fumarate and Entcavir in Treatment of Chronic Hepatitis B Patients in Upper Egypt
NCT05874440 ·Status: UNKNOWN
-
Composite Probiotics Stabilize Lipid Metabolism in Chronic Hepatitis B Patients:A Clinical Trial
NCT06221605 ·Status: COMPLETED ·Phase: NA
-
The Study on Optimal Treatment and Clinical Outcome of Chronic Hepatitis B Patients With Inactive Hypoviremia
NCT05357235 ·Status: UNKNOWN
-
Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection
NCT00023153 ·Status: COMPLETED ·Phase: PHASE3
-
Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult Subjects
NCT01289106 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 Weeks
NCT00862706 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant Patients
NCT00722332 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B
NCT01743079 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
NCT00037622 ·Status: TERMINATED ·Phase: NA
-
Tenofovir in Pregnancy to Prevent Mother to Child Transmission of Hepatitis B.
NCT04114890 ·Status: COMPLETED ·Phase: PHASE2
-
Withdrawal of Therapy After Long-Term Antiviral Treatment for Chronic Hepatitis B
NCT01581554 ·Status: COMPLETED
-
Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients
NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2
-
Reducing Vertical Transmission of Hepatitis B in Africa
NCT04704024 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)
NCT00804622 ·Status: COMPLETED ·Phase: PHASE2
-
Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis B
NCT04629976 ·Status: COMPLETED ·Phase: PHASE1